We are live on
!
Find out more
SGYP
Synergy Pharmaceuticals, Inc Common Stock
SGYP
SGYP
Delisted
SGYP was delisted on the 7th of March, 2019.
146 hedge funds and large institutions have $717M invested in Synergy Pharmaceuticals, Inc Common Stock in 2017 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 67 increasing their positions, 27 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
148% more repeat investments, than reductions
Existing positions increased: 67 | Existing positions reduced: 27
1% more capital invested
Capital invested by funds: $708M → $717M (+$8.92M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
11% less funds holding
Funds holding: 164 → 146 (-18)
12% less call options, than puts
Call options by funds: $7.57M | Put options by funds: $8.63M
42% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 38
Holders
146
Holders Change
-18
Holders Change %
-10.98%
% of All Funds
3.64%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
22
Increased
67
Reduced
27
Closed
38
Calls
$7.57M
Puts
$8.63M
Net Calls
-$1.05M
Net Calls Change
+$4.04M
Top Buyers
| 1 |
TCP
Tourbillon Capital Partners
New York
|
+$17.1M |
| 2 |
BlackRock
New York
|
+$8.87M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$6.75M |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$5.9M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$4.47M |
Top Sellers
| 1 |
KCM
Kingdon Capital Management
New York
|
-$5.21M |
| 2 |
PA
Perceptive Advisors
New York
|
-$4.56M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$4.13M |
| 4 |
GL
Governors Lane
New York
|
-$4.05M |
| 5 |
ACM
Asymmetry Capital Management
San Francisco,
California
|
-$2.97M |
